MedPath

Intravenous Immunoglobulin decrease rate of Immunologic Abortio

Not Applicable
Conditions
Abortion.
Supervision of pregnancy with history of abortive outcome
Registration Number
IRCT2015021220993N2
Lead Sponsor
Vice chancellor of research in Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

inclusion criteria: women with at least two abortions that had taken place naturally or with assisted reproductive techniques (ART) and who had at least one positive immunologic test for anti-cardiolipin; anti-phospholipid antibodies;anti-thyroid antibody; anti-nuclear antibody;Anti-sperm antibody.
Exclusion criteria: anatomical problems; infections; hormonal factors contributing to recurrent abortion and parental factors were excluded.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eonate. Timepoint: 9 month. Method of measurement: Delivery.
Secondary Outcome Measures
NameTimeMethod
Abortion. Timepoint: Each time after intervention. Method of measurement: exposing symptoms of abortion.;Premature birth. Timepoint: Each time after intervention. Method of measurement: exposing symptoms of premature birth.
© Copyright 2025. All Rights Reserved by MedPath